HUNTSVILLE, Ala. — Qualitest Pharmaceuticals has received approval from the Food and Drug Administration to market acetaminophen and codeine phosphate oral solution, 120mg/12mg per 5ml.
The generic drug manufacturer said Monday that sales for acetaminophen and codeine phosphate oral solution in the United States totaled $4.3 million for the 12 months ended Sept. 30, based on data from IMS Health.
Acetaminophen and codeine phosphate oral solution is indicated for the relief of mild to moderate pain.
